Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer’s disease

Overview of attention for article published in Alzheimer's Research & Therapy, May 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)

Mentioned by

news: 1 news outlet

twitter: 2 X users

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 29 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 12,324 followers.

Glycoprotein NMB (GPNMB) is really interesting, but an evaluation of cerebrospinal fluid levels of GPNMB as a potential biomarker for #Alzheimers indicates "No" (not a perfect control/comparative group though); Validates a commercial GPNMB immunoassay http

06 May 2021

Reply Repost Favourite

Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer’s disease https://t.co/CbrUjf59Nn https://t.co/RwnmdqXKE4

05 May 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.